A. Alietti

Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patients

R. Foà, S. Molica, S. Chiaretti, 2014, American journal of hematology.

Rituximab Plus Chlorambucil As Initial Treatment for Elderly Patients with Chronic Lymphocytic Leukemia (CLL): Effect of Pre-Treatment Biological Characteristics and Gene Expression Patterns on Response to Treatment

R. Foà, S. Molica, S. Chiaretti, 2011 .

A phase II study of chlorambucil plus rituximab followed by maintenance versus observation in elderly patients with previously untreated chronic lymphocytic leukemia: Results of the induction phase.

S. Molica, A. Guarini, A. Cuneo, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunoreactivity for cyclin D1 is a reliable marker of gene aberration in plasma cell myeloma but does not specify patients prognosis.

S. Pileri, G. Pruneri, G. Viale, 2008, Leukemia research.

Magnetic resonance imaging of primary breast lymphoma

G. Pruneri, M. Bellomi, G. Martinelli, 2009, La radiologia medica.

Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers.

G. Martinelli, F. Bertolini, E. Zucca, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group.

F. Cavalli, A. Taghian, G. Pruneri, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Tissue Microarrays in Diffuse Large B-Cell Lymphomas

D. Radice, G. Pruneri, G. Martinelli, 2011, International journal of surgical pathology.

Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa.

L. Baldini, A. Neri, M. Colombi, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Is there a role for ‘modified VAD’ in the treatment of multiple myeloma?

G. Pruneri, G. Martinelli, P. Mancuso, 2009, Ecancermedicalscience.

Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patients

R. Foà, S. Molica, S. Chiaretti, 2014, American journal of hematology.